IL-22 also stimulates sphingosine-1-phosphate (S1P) production in mesenchymal stem cells (MSCs) and promotes the chemotactic migration of breast tumor cells toward MSCs, thereby enhancing BC metastasis to bone marrow. Here, IL22 is linked to breast cancer.